Risk of Leukemia after Platinum-Based Chemotherapy for Ovarian Cancer

Abstract

Platinum-based treatment of ovarian cancer increases the risk of secondary leukemia. Nevertheless, the substantial benefit that platinum-based treatment offers patients with advanced disease outweighs the relatively small excess risk of leukemia.